Fierce Pharma: DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets

DNA molecule forming inside test tube

Karen Fallen’s appointment as CEO of Touchlight DNA Services featured in Kyle Blankenship’s article in Fierce Pharma.

Read more